1. Home
  2. NSIT vs WVE Comparison

NSIT vs WVE Comparison

Compare NSIT & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insight Enterprises Inc.

NSIT

Insight Enterprises Inc.

HOLD

Current Price

$81.05

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$7.13

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSIT
WVE
Founded
1988
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
NSIT
WVE
Price
$81.05
$7.13
Analyst Decision
Hold
Strong Buy
Analyst Count
4
16
Target Price
$116.25
$29.81
AVG Volume (30 Days)
491.6K
3.9M
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.97
N/A
Revenue
$8,247,180,000.00
$3,704,000.00
Revenue This Year
$3.79
N/A
Revenue Next Year
$2.16
$85.67
P/E Ratio
$85.51
N/A
Revenue Growth
N/A
149.43
52 Week Low
$63.62
$5.02
52 Week High
$148.36
$21.73

Technical Indicators

Market Signals
Indicator
NSIT
WVE
Relative Strength Index (RSI) 64.79 39.65
Support Level $79.24 $6.81
Resistance Level $87.42 $7.67
Average True Range (ATR) 4.60 0.36
MACD 0.36 0.16
Stochastic Oscillator 84.63 34.67

Price Performance

Historical Comparison
NSIT
WVE

About NSIT Insight Enterprises Inc.

Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, government agencies, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital workplace, cloud/data center transformation, IT modernization, Cyber Security and supply chain optimization solutions and services.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: